New combo treatment aims to shrink tumors before surgery in advanced rectal cancer
NCT ID NCT07478731
Summary
This study is testing whether adding the experimental drug SHR-1701 to standard chemotherapy and radiation before surgery helps treat locally advanced rectal cancer. The goal is to shrink tumors as much as possible to improve surgical outcomes. About 48 adults with advanced rectal cancer who haven't had prior treatment will receive the combination therapy followed by surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRC (COLORECTAL CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.